| Alexander S Urioste, MD | |
|
8881 Fletcher Parkway, #102, La Mesa, CA 91942 | |
| (619) 461-1830 | |
| (619) 797-1484 |
| Full Name | Alexander S Urioste |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 24 Years |
| Location | 8881 Fletcher Parkway, La Mesa, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528011020 | NPI | - | NPPES |
| 00A787950 | Other | CA | BLUE SHIELD PIN |
| 00A787950 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | A78795 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Grossmont Hospital | La mesa, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| X-ray Medical Group Inc | 5294796801 | 38 |
News Archive
LifeVantage Corporation (OTCBB: LFVN), a science-based, natural products company dedicated to helping people reach their health and wellness goals through science-based solutions for oxidative stress and the maker of Protandim® and TrueScience™ Anti-Aging Cream, announced today that independent distributor applications and orders are being accepted in Mexico in anticipation of a launch late this summer.
ConforMIS, Inc., a privately held medical device company pioneering patient-specific orthopedic implants, announced today it has expanded its Series E financing to $167.7 million with participation from top-tier Sovereign Wealth Funds, Government Investment Funds and Private Equity Funds in the U.S., Europe, Asia and the Middle East.
A team of scientists from the University of Oxford, UK, has revealed that site-specific glycosylation differs between spike proteins derived from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and a viral vector-based vaccine candidate.
Universally screening pediatric patients for COVID-19 before they undergo surgical procedures has allowed hospitals to improve safety by identifying all patients who test positive for the virus, half of whom have no symptoms, according to new research led by Children's Hospital of Philadelphia
Doctors in the U.S. and Japan have devised a way to treat atrial fibrillation by adding a little alcohol to minimally invasive therapies that target a cluster of misbehaving nerves known to trigger arrhythmia. In the most recent Journal of the American College of Cardiology (online before print), the researchers say the new therapy may dull or stop the transmission of electrical impulses that cause atrial fibrillation.
› Verified 1 days ago
| Entity Name | Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558463927 PECOS PAC ID: 3577476761 Enrollment ID: O20040107000584 |
News Archive
LifeVantage Corporation (OTCBB: LFVN), a science-based, natural products company dedicated to helping people reach their health and wellness goals through science-based solutions for oxidative stress and the maker of Protandim® and TrueScience™ Anti-Aging Cream, announced today that independent distributor applications and orders are being accepted in Mexico in anticipation of a launch late this summer.
ConforMIS, Inc., a privately held medical device company pioneering patient-specific orthopedic implants, announced today it has expanded its Series E financing to $167.7 million with participation from top-tier Sovereign Wealth Funds, Government Investment Funds and Private Equity Funds in the U.S., Europe, Asia and the Middle East.
A team of scientists from the University of Oxford, UK, has revealed that site-specific glycosylation differs between spike proteins derived from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and a viral vector-based vaccine candidate.
Universally screening pediatric patients for COVID-19 before they undergo surgical procedures has allowed hospitals to improve safety by identifying all patients who test positive for the virus, half of whom have no symptoms, according to new research led by Children's Hospital of Philadelphia
Doctors in the U.S. and Japan have devised a way to treat atrial fibrillation by adding a little alcohol to minimally invasive therapies that target a cluster of misbehaving nerves known to trigger arrhythmia. In the most recent Journal of the American College of Cardiology (online before print), the researchers say the new therapy may dull or stop the transmission of electrical impulses that cause atrial fibrillation.
› Verified 1 days ago
| Entity Name | X-ray Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740232776 PECOS PAC ID: 5294796801 Enrollment ID: O20041026000600 |
News Archive
LifeVantage Corporation (OTCBB: LFVN), a science-based, natural products company dedicated to helping people reach their health and wellness goals through science-based solutions for oxidative stress and the maker of Protandim® and TrueScience™ Anti-Aging Cream, announced today that independent distributor applications and orders are being accepted in Mexico in anticipation of a launch late this summer.
ConforMIS, Inc., a privately held medical device company pioneering patient-specific orthopedic implants, announced today it has expanded its Series E financing to $167.7 million with participation from top-tier Sovereign Wealth Funds, Government Investment Funds and Private Equity Funds in the U.S., Europe, Asia and the Middle East.
A team of scientists from the University of Oxford, UK, has revealed that site-specific glycosylation differs between spike proteins derived from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and a viral vector-based vaccine candidate.
Universally screening pediatric patients for COVID-19 before they undergo surgical procedures has allowed hospitals to improve safety by identifying all patients who test positive for the virus, half of whom have no symptoms, according to new research led by Children's Hospital of Philadelphia
Doctors in the U.S. and Japan have devised a way to treat atrial fibrillation by adding a little alcohol to minimally invasive therapies that target a cluster of misbehaving nerves known to trigger arrhythmia. In the most recent Journal of the American College of Cardiology (online before print), the researchers say the new therapy may dull or stop the transmission of electrical impulses that cause atrial fibrillation.
› Verified 1 days ago
| Entity Name | Ihs Radiology Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497148456 PECOS PAC ID: 1052622024 Enrollment ID: O20150617000811 |
News Archive
LifeVantage Corporation (OTCBB: LFVN), a science-based, natural products company dedicated to helping people reach their health and wellness goals through science-based solutions for oxidative stress and the maker of Protandim® and TrueScience™ Anti-Aging Cream, announced today that independent distributor applications and orders are being accepted in Mexico in anticipation of a launch late this summer.
ConforMIS, Inc., a privately held medical device company pioneering patient-specific orthopedic implants, announced today it has expanded its Series E financing to $167.7 million with participation from top-tier Sovereign Wealth Funds, Government Investment Funds and Private Equity Funds in the U.S., Europe, Asia and the Middle East.
A team of scientists from the University of Oxford, UK, has revealed that site-specific glycosylation differs between spike proteins derived from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and a viral vector-based vaccine candidate.
Universally screening pediatric patients for COVID-19 before they undergo surgical procedures has allowed hospitals to improve safety by identifying all patients who test positive for the virus, half of whom have no symptoms, according to new research led by Children's Hospital of Philadelphia
Doctors in the U.S. and Japan have devised a way to treat atrial fibrillation by adding a little alcohol to minimally invasive therapies that target a cluster of misbehaving nerves known to trigger arrhythmia. In the most recent Journal of the American College of Cardiology (online before print), the researchers say the new therapy may dull or stop the transmission of electrical impulses that cause atrial fibrillation.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alexander S Urioste, MD 7777 Alvarado Rd, #108, La Mesa, CA 91942 Ph: (619) 460-2770 | Alexander S Urioste, MD 8881 Fletcher Parkway, #102, La Mesa, CA 91942 Ph: (619) 461-1830 |
News Archive
LifeVantage Corporation (OTCBB: LFVN), a science-based, natural products company dedicated to helping people reach their health and wellness goals through science-based solutions for oxidative stress and the maker of Protandim® and TrueScience™ Anti-Aging Cream, announced today that independent distributor applications and orders are being accepted in Mexico in anticipation of a launch late this summer.
ConforMIS, Inc., a privately held medical device company pioneering patient-specific orthopedic implants, announced today it has expanded its Series E financing to $167.7 million with participation from top-tier Sovereign Wealth Funds, Government Investment Funds and Private Equity Funds in the U.S., Europe, Asia and the Middle East.
A team of scientists from the University of Oxford, UK, has revealed that site-specific glycosylation differs between spike proteins derived from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and a viral vector-based vaccine candidate.
Universally screening pediatric patients for COVID-19 before they undergo surgical procedures has allowed hospitals to improve safety by identifying all patients who test positive for the virus, half of whom have no symptoms, according to new research led by Children's Hospital of Philadelphia
Doctors in the U.S. and Japan have devised a way to treat atrial fibrillation by adding a little alcohol to minimally invasive therapies that target a cluster of misbehaving nerves known to trigger arrhythmia. In the most recent Journal of the American College of Cardiology (online before print), the researchers say the new therapy may dull or stop the transmission of electrical impulses that cause atrial fibrillation.
› Verified 1 days ago
Dr. Jonathan Tiefenbrun, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 8851 Center Dr, Ste 505, La Mesa, CA 91942 Phone: 619-461-3880 Fax: 619-461-3895 | |
Dr. Tuan Xuan Ha, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 5555 Grossmont Center Dr, La Mesa, CA 91942 Phone: 619-740-4000 | |
Dr. Scott Carey Honowitz, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5555 Grossmont Center Dr, La Mesa, CA 91942 Phone: 619-740-4005 Fax: 619-740-4207 | |
James C Jacobsen, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 8881 Fletcher Parkway, #102, La Mesa, CA 91942 Phone: 619-461-1830 Fax: 619-797-1484 | |
Dr. Charles Kerber, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 4444 Topa Topa Dr, La Mesa, CA 91941 Phone: 760-598-8058 Fax: 760-598-8078 | |
Dr. Alex Wang Sun, M.D Radiology Medicare: Accepting Medicare Assignments Practice Location: 5555 Grossmont Center Dr, La Mesa, CA 91942 Phone: 619-740-4008 |